Оптимизация антибиотико-терапии больных хроническим пиелонефритом, который сочетается с сахарным диабетом 2 типа путем оценки экспрессии плазмидных генов резистентности
DOI :
https://doi.org/10.15587/2313-8416.2015.47376Mots-clés :
хронический пиелонефрит, сахарный диабет 2 тип, антибиотико-терапия, резистентность, плазмиды, гены.Résumé
Изучена распространенность плазмид-индуцированных механизмов резистентности у пациентов, страдающих хроническим пиелонефритом на фоне сахарного диабета 2 типа; установлены взаимосвязи резистентности in vitro к антибактериальным препаратам с наличием различных типов плазмидных генов устойчивости; разработаны методы дифференцированного назначения антибиотико-терапии больных хроническим пиелонефритом, который протекает на фоне сахарного диабета 2 типа в зависимости от экспрессии различных типов плазмидных генов устойчивости
Références
Kolesnik, M. O, Saydakova, N. A., Kozlyuk, N. I., Nikolaenko, S. (2013). Medical and preventive care to patients Nephrology Profile 2009-2012 what should to do next? Ukrainian Journal of Nephrology and Dialysis, 3 (39), 3–14.
Kolesnik, N. A. (2009). Kidneys and Diabetes: from understanding the problem to timely and adequate therapy. Ukrainian Journal of Nephrology and Dialysis, 13–14, 13–15.
Srinivas M., Chandrashekar UK., Shivashankara, K. N., Pruthvi, B. C. (2014). Clinical profile of urinary tract infections in diabetics and non-diabetics. AMJ, 7 (1), 29–34. doi: 10.4066/amj.2014.1906
Kolesnik, M. O., Stepanova, N. (2007). Etiological range of urinary tract infections. Ukrainian Journal of Nephrology and Dialysis, 3 (15), 16–29.
Carattoli, A. (2011). Plasmids in Gram negatives: Molecular typing of resistance plasmids. International Journal of Medical Microbiology, 301 (8), 654–658. doi: 10.1016/j.ijmm.2011.09.003
Kolesnik, M. O., Dudar, I., Stepanova, N. et al. (2012). Adapted clinical instruction for the better practice of diagnosis, treatment and prevention of urinary tract infections in women. Ukrainian Journal of Nephrology and Dialysis, 2 (34), 53–77.
Curcio, D. (2013). Multidrug-Resistant Gram-Negative Bacterial Infections: Are you Ready for the Challenge? Curr Clin Pharmacol., 12, 13–22.
Valenza, G., Nickel, S., Pfeifer, Y. (2014). Extended-Spectrum-β-Lactamase-Producing Escherichia coli as Intestinal Colonizers in the German Community. Antimicrob Agents Chemother., 58 (2), 1228–1230.
Poirel, L., Cattoir, V., Nordmann, P. (2012). Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies. Frontiers in Microbiology, 3 (24), 1–7. doi: 10.3389/fmicb.2012.00024
Kolesnik, M. O., Dudar, I., Stepanova, N. et al. (2013). Classification of the urinary tract diseases for nephrological practice. Ukrainian Journal of Nephrology and Dialysis, 4 (40), 3–7.
Sundsfjord, A. (2005). Genetic methods for detection of antimicrobial resistance. DAHLAPMIS, 12, 815–837.
Grabe, M. (2015). Guidelines on Urological Infections. European Association of Urology, 182.
Søraas, A., Sundsfjord, A., Jørgensen, S. B., Liestøl, K., Jenum, P. A. (2014). High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli. PLoS ONE, 9 (1), e85889. doi: 10.1371/journal.pone.0085889
Frakking, F. N., Rottier, W. C., Dorigo-Zetsma, J. W., van Hattem, J. M. et al. (2013). Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria. Antimicrob Agents Chemother., 57 (7), 3092–3099.
Téléchargements
Publié-e
Numéro
Rubrique
Licence
(c) Tous droits réservés Ольга Игоревна Чуб, Александр Викторович Бильченко 2015
Cette œuvre est sous licence Creative Commons Attribution 4.0 International.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
